These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6982230)

  • 21. Complement depletion aggravates Staphylococcus aureus septicaemia and septic arthritis.
    Sakiniene E; Bremell T; Tarkowski A
    Clin Exp Immunol; 1999 Jan; 115(1):95-102. PubMed ID: 9933426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics/Pharmacodynamics of Peptide Deformylase Inhibitor GSK1322322 against Streptococcus pneumoniae, Haemophilus influenzae, and Staphylococcus aureus in Rodent Models of Infection.
    Hoover J; Lewandowski T; Straub RJ; Novick SJ; DeMarsh P; Aubart K; Rittenhouse S; Zalacain M
    Antimicrob Agents Chemother; 2016 Jan; 60(1):180-9. PubMed ID: 26482300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD11b limits bacterial outgrowth and dissemination during murine pneumococcal pneumonia.
    Rijneveld AW; de Vos AF; Florquin S; Verbeek JS; van der Poll T
    J Infect Dis; 2005 May; 191(10):1755-60. PubMed ID: 15838804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cimetidine does not impair lung host defense in experimental pneumococcal pneumonia.
    Esposito AL
    Am Rev Respir Dis; 1987 Aug; 136(2):320-4. PubMed ID: 3619190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amino acid changes affecting the activity of pneumolysin alter the behaviour of pneumococci in pneumonia.
    Alexander JE; Berry AM; Paton JC; Rubins JB; Andrew PW; Mitchell TJ
    Microb Pathog; 1998 Mar; 24(3):167-74. PubMed ID: 9514638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Host cellular immune response to pneumococcal lung infection in mice.
    Kadioglu A; Gingles NA; Grattan K; Kerr A; Mitchell TJ; Andrew PW
    Infect Immun; 2000 Feb; 68(2):492-501. PubMed ID: 10639409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Alpha-Tocopherol Form of Vitamin E Boosts Elastase Activity of Human PMNs and Their Ability to Kill
    Bou Ghanem EN; Lee JN; Joma BH; Meydani SN; Leong JM; Panda A
    Front Cell Infect Microbiol; 2017; 7():161. PubMed ID: 28516066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. On the nature of bacteremia in experimental pneumococcal pneumonia in the dog. I. Relationship of natural pneumococcidal-promoting activity of the serum to blood invasion.
    ROBERTSON OH; HAMBURGER M; GREGG LA
    J Exp Med; 1953 Feb; 97(2):283-96. PubMed ID: 13022879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin-10 impairs host defense in murine pneumococcal pneumonia.
    van der Poll T; Marchant A; Keogh CV; Goldman M; Lowry SF
    J Infect Dis; 1996 Nov; 174(5):994-1000. PubMed ID: 8896500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nebulized C1-Esterase Inhibitor does not Reduce Pulmonary Complement Activation in Rats with Severe Streptococcus Pneumoniae Pneumonia.
    de Beer F; Lagrand W; Glas GJ; Beurskens CJ; van Mierlo G; Wouters D; Zeerleder S; Roelofs JJ; Juffermans NP; Horn J; Schultz MJ
    Cell Biochem Biophys; 2016 Dec; 74(4):545-552. PubMed ID: 27683129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. STUDIES ON THE MECHANISM OF RECOVERY IN PNEUMOCOCCAL PNEUMONIA : II. THE EFFECT OF SULFONAMIDE THERAPY UPON THE PULMONARY LESION OF EXPERIMENTAL PNEUMONIA.
    Wood WB; Irons EN
    J Exp Med; 1946 Sep; 84(4):365-76. PubMed ID: 19871575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of activation-induced cytidine deaminase enhances the clearance of pneumococcal pneumonia: evidence of a subpopulation of protective anti-pneumococcal B1a cells.
    Yamamoto N; Kerfoot SM; Hutchinson AT; Dela Cruz CS; Nakazawa N; Szczepanik M; Majewska-Szczepanik M; Nazimek K; Ohana N; Bryniarski K; Mori T; Muramatsu M; Kanemitsu K; Askenase PW
    Immunology; 2016 Jan; 147(1):97-113. PubMed ID: 26456931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of gamma interferon in the pathogenesis of bacteremic pneumococcal pneumonia.
    Rubins JB; Pomeroy C
    Infect Immun; 1997 Jul; 65(7):2975-7. PubMed ID: 9199475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alveolar macrophage apoptosis contributes to pneumococcal clearance in a resolving model of pulmonary infection.
    Dockrell DH; Marriott HM; Prince LR; Ridger VC; Ince PG; Hellewell PG; Whyte MK
    J Immunol; 2003 Nov; 171(10):5380-8. PubMed ID: 14607941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The contribution of PspC to pneumococcal virulence varies between strains and is accomplished by both complement evasion and complement-independent mechanisms.
    Kerr AR; Paterson GK; McCluskey J; Iannelli F; Oggioni MR; Pozzi G; Mitchell TJ
    Infect Immun; 2006 Sep; 74(9):5319-24. PubMed ID: 16926426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin 1 receptor-associated kinase m impairs host defense during pneumococcal pneumonia.
    van der Windt GJ; Blok DC; Hoogerwerf JJ; Lammers AJ; de Vos AF; Van't Veer C; Florquin S; Kobayashi KS; Flavell RA; van der Poll T
    J Infect Dis; 2012 Jun; 205(12):1849-57. PubMed ID: 22492852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of the elastase inhibitor, eglin-c, on antibacterial mechanisms in experimental pneumonia. Description of a system to quantitate phagocytic and bactericidal activity of resident murine alveolar macrophages in vivo.
    Esposito AL; Quinn LA; Lucey EC; Snider GL
    Am Rev Respir Dis; 1987 Mar; 135(3):676-81. PubMed ID: 3644606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urokinase receptor is necessary for adequate host defense against pneumococcal pneumonia.
    Rijneveld AW; Levi M; Florquin S; Speelman P; Carmeliet P; van Der Poll T
    J Immunol; 2002 Apr; 168(7):3507-11. PubMed ID: 11907112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Staphylococcus aureus elicits marked alterations in the airway proteome during early pneumonia.
    Ventura CL; Higdon R; Hohmann L; Martin D; Kolker E; Liggitt HD; Skerrett SJ; Rubens CE
    Infect Immun; 2008 Dec; 76(12):5862-72. PubMed ID: 18852243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polyamine transporter in Streptococcus pneumoniae is essential for evading early innate immune responses in pneumococcal pneumonia.
    Rai AN; Thornton JA; Stokes J; Sunesara I; Swiatlo E; Nanduri B
    Sci Rep; 2016 Jun; 6():26964. PubMed ID: 27247105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.